Canakinumab
Product Specifications
CAS Number
914613-48-2
Target
IL Receptor, Interleukin
Related Pathways
Immunology/Inflammation
Purity
0.988
Bioactivity
Canakinumab (ACZ885) is a recombinant human IL-1β-targeting monoclonal antibody that inhibits human and chorioallantoic monkey IL-1β with IC50 values of 43.6 and 40.8 pM, respectively. It exhibits anti-inflammatory activity by neutralizing IL-1β signaling, and it has been used for the treatment of gout and coronary artery disease.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1461383-01 0.02 mg (E-Coli)
Recombinant Bacillus cereus tRNA pseudouridine synthase B (truB)
Sign In for Pricing
View Details MBS1461383-02 0.02 mg (Yeast)
Recombinant Bacillus cereus tRNA pseudouridine synthase B (truB)
Sign In for Pricing
View Details